Back to top
more

Encompass Health (EHC)

(Delayed Data from NYSE)

$94.50 USD

94.50
426,967

-0.23 (-0.24%)

Updated Oct 4, 2024 04:00 PM ET

After-Market: $94.48 -0.02 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 18% (45 out of 252)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Encompass Health (EHC) Set to Widen Presence in South Carolina

by Zacks Equity Research

Encompass Health (EHC) reveals plans to construct a 27-bed hospital in South Carolina aimed at providing high-quality rehabilitative care throughout the state.

Zacks.com featured highlights include: Celestica, Encompass Health, Atlas Corp, DXC Technology and Conn's

by Zacks Equity Research

Zacks.com featured highlights include: Celestica, Encompass Health, Atlas Corp, DXC Technology and Conn's

Sumit Singh headshot

Pick These 5 Low P/CF Stocks to Garner Superior Returns

by Sumit Singh

Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Celestica (CLS), Encompass Health (EHC), Atlas (ATCO), DXC Technology (DXC) and Conn's (CONN) boast low P/CF ratio.

Encompass Health (EHC) Misses on Q3 Earnings, Cuts '21 EPS View

by Zacks Equity Research

Encompass Health's (EHC) third-quarter earnings miss estimates but improve year over year on the back of top-line growth resulting from a sound Inpatient Rehabilitation segment.

Encompass Health (EHC) Q3 Earnings and Revenues Lag Estimates

by Zacks Equity Research

Encompass Health (EHC) delivered earnings and revenue surprises of -3.74% and -2.38%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Is Encompass Health (EHC) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Encompass Health (EHC) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Encompass Health (EHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks.com featured highlights include: Foot Locker, Hibbett, Group 1 Automotive, Teck Resources and Encompass Health

by Zacks Equity Research

Zacks.com featured highlights include: Foot Locker, Hibbett, Group 1 Automotive, Teck Resources and Encompass Health

Kinjel Shah headshot

Buy These 7 Best Value Stocks to Make the Most of P/B Ratio

by Kinjel Shah

P/B ratio is emerging as a convenient tool for identifying low-priced stocks that have high growth prospects.

Walgreens (WBA) to Make Additional Investment in VillageMD

by Zacks Equity Research

Walgreens (WBA) announced a $5.2-billion investment in VillageMD to bolster its strategic position in delivering value-based primary care.

Encompass Health (EHC) Rides on Solid Revenues, Expansion Plans

by Zacks Equity Research

Encompass Health (EHC) continues to gain, courtesy of sustained growth in revenues, sound expansion endeavors across the United States and a robust 2021 business outlook.

    LHC Group (LHCG) Finalizes Home Health & Hospice Buyout Deals

    by Zacks Equity Research

    LHC Group (LHCG) to expand in Virginia Beach with the completion of the previously announced acquisition agreements with two providers, one in home health and the other in hospice.

    Zacks.com featured highlights include: Hibbett, Encompass Health, Berry Global Group, Vishay Intertechnology and Affiliated Managers Group

    by Zacks Equity Research

    Zacks.com featured highlights include: Hibbett, Encompass Health, Berry Global Group, Vishay Intertechnology and Affiliated Managers Group

    Sumit Singh headshot

    Pick These 5 Low P/CF Stocks for a Value-Based Portfolio

    by Sumit Singh

    Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Hibbett (HIBB), Encompass Health (EHC), Berry Global (BERY), Vishay Intertechnology (VSH) and Affiliated Managers (AMG) boast low P/CF ratio.

    Should Value Investors Buy Encompass Health (EHC) Stock?

    by Zacks Equity Research

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

    UnitedHealth (UNH) Unit Ties Up to Offer Quality Care in Midwest

    by Zacks Equity Research

    UnitedHealth Group's (UNH) subsidiary Optum collaborates with SSM Health in a bid to employ advanced technologies and insights for delivering better health outcomes across the Midwest.

    EHC or AMED: Which Is the Better Value Stock Right Now?

    by Zacks Equity Research

    EHC vs. AMED: Which Stock Is the Better Value Option?

    Zacks Industry Outlook Highlights: Encompass Health, RadNet, U.S. Physical Therapy and Quest Diagnostics

    by Zacks Equity Research

    Zacks Industry Outlook Highlights: Encompass Health, RadNet, U.S. Physical Therapy and Quest Diagnostics

    Trina Mukherjee headshot

    3 Top Stocks From the Buoyant Outpatient Home Health Industry

    by Trina Mukherjee

    Despite the COVID-19 pandemic induced challenges, rising dependence on telehealth and AI's dominant role are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. EHC, RDNT and USPH are well-poised to gain from the prospects.

    Sumit Singh headshot

    Pick These 5 Low P/CF Stocks for a Balanced Portfolio

    by Sumit Singh

    Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Boise Cascade (BCC), Encompass Health (EHC), Hibbett (HIBB), Celestica (CLS) and Flex Ltd. (FLEX) boast low P/CF ratio.

    New Strong Buy Stocks for September 21st

    by Zacks Equity Research

    CASY, DSKE, EHC, GIII, and STRL have been added to the Zacks Rank #1 (Strong Buy) List on September 21, 2021.

    What Makes Encompass Health (EHC) a New Strong Buy Stock

    by Zacks Equity Research

    Encompass Health (EHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

    EHC or AMED: Which Is the Better Value Stock Right Now?

    by Zacks Equity Research

    EHC vs. AMED: Which Stock Is the Better Value Option?

    HealthEquity (HQY) Q2 Earnings & Revenues Beat Estimates

    by Zacks Equity Research

    HealthEquity (HQY) witnesses solid growth in HSAs and records robust Interchange revenues in the second quarter of fiscal 2022.

    Urmimala Biswas headshot

    3 MedTech Sectors Benefiting Despite COVID-19 Resurgence

    by Urmimala Biswas

    Here we discuss three major subsectors of MedTech and some of their constituent stocks for which COVID-19 has opened up enormous growth prospects.